CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Risperidone +2 moredrug
Likely dose
Risperidone 0.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00389493
NCT00389493N/ACompleted
CompareCT.gov

Maximizing Treatment Outcome in OCD

New York State Psychiatric Institute·interventional·Posted Oct 18, 2006·Updated Apr 25, 2014

In Brief

A clinical study evaluating Risperidone, Exposure/ritual prevention therapy (EX/RP), and 1 other intervention for Obsessive-Compulsive Disorder. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

This study will compare the short- and long-term effectiveness of two common therapies in improving serotonin reuptake inhibitor treatment in people with obsessive-compulsive disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive-Compulsive Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 18, 2006
Enrollment StartOct 1, 2006
Primary CompletionJun 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 19.7 years ago

Interventions

Risperidonedrug

Dosage of 0.5 mg to 4.0 mg per day as tolerated

Exposure/ritual prevention therapy (EX/RP)behavioral

EX/RP is a form of cognitive behavioral therapy. Participants assigned to EX/RP will attend therapy sessions twice per week. In EX/RP, participants will be exposed to feared objects or ideas, and will be encouraged not to carry out a compulsive response.

Placebodrug

Placebo capsules will be identical in appearance to those of risperidone.